hers oral tirzepatide Thinking About Using Hers' Weight Loss Medications? Here's Everything You Should Know Oral Tirzepatide | Tablet Health

YES Approved as Egrifta Approved indication

Rep 76 , 754779 (2024)

Animal Toxicology Studies Animal toxicology studies tested doses from 0.0027 mg/lb to 9.1 mg/lb via intraperitoneal, intramuscular, intravenous, and oral routes for up to 6 weeks, finding: No acute toxic or lethal dose No gross or histologic toxicity in major organs No hepatotoxicity or nephrotoxicity Negative Ames test (no mutagenicity) Negative chromosomal aberration tests (no genotoxicity) No teratogenicity in rat pregnancy studies No local injection site irritation The LD1 (minimum lethal dose) could not be achieved despite aggressive testing

In This Article What Is L-Carnitine